{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:01:02Z","timestamp":1790719262412,"version":"4.1.0"},"reference-count":23,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1994,3]]},"abstract":"<jats:p>AIMS--To identify the relative contribution of plasminogen activators, particularly tissue plasminogen activator (t-PA) and specific plasminogen activator inhibitors (PAI-1, PAI-2), to the fibrinolytic changes associated with various types of liver disease or severe chemical and physical damage to the liver. METHODS--Platelet rich (PRP) and platelet poor plasma (PFP) from patients with alcoholic cirrhosis, primary biliary cirrhosis, hepatic malignancy, or paracetamol overdose, or who were undergoing partial hepatectomy or liver transplantation, were assayed for t-PA, PAI-1, t-PA-PAI-1 complex and PAI-2 antigen values using specific enzyme linked immunosorbent assays (ELISAs) developed in this laboratory. RESULTS--Appreciable increases in the plasma concentration of t-PA, PAI-1, and t-PA-PAI-1 were seen in patients with alcoholic cirrhosis, primary biliary cirrhosis, and hepatic malignancy. Liver damage due to paracetamol overdose and partial hepatectomy both resulted in a striking increase in plasma PAI-1 concentration, although concentrations of t-PA and t-PA-PAI-1 complex were less affected. Concentrations of t-PA, PAI-1, and t-PA-PAI-1 complex returned to near normal values after successful liver transplantation in a patient with chronic active hepatitis. PAI-2 was also detected in several patients with chronic liver disorders. CONCLUSIONS--Haemorrhage due to fibrinolytic bleeding is commonly associated with liver disease. The patients studied here all had appreciable increases in circulating t-PA antigen concentrations. This was associated with increased concentrations of PAI-1 antigen and t-PA-PAI-1 complex and the balance between activator and inhibitor did not result in systemic plasmin generation. Reduced PAI-1 activity in cirrhosis or a critical difference in the ratio of t-PA to PAI-1 concentrations may explain the enhanced plasminogen activator activity previously noted in cirrhosis but not metastatic disease. Reduced hepatic clearance of t-PA and t-PA-PAI-1 complex due to impaired liver function may account for increased concentrations of free and complexed t-PA.<\/jats:p>","DOI":"10.1136\/jcp.47.3.214","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"214-217","source":"Crossref","is-referenced-by-count":42,"title":["Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease."],"prefix":"10.1136","volume":"47","author":[{"given":"K","family":"Leiper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Croll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N A","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N R","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1994,3,1]]},"reference":[{"key":"ref_1","first-page":"29","article-title":"Studies on a proteolytic enzyme in human plasma IV. The rate of lysis of plasma clots in normal and diseased individuals with particular reference to hepatic disease","volume":"84","author":"Ratnoff, O.D.","year":"1949","unstructured":"Ratnoff OD. Studies on a proteolytic enzyme in human plasma IV. The rate of lysis of plasma clots in normal and diseased individuals with particular reference to hepatic disease. Bulletin of the Johns Hospital 1949;84: 29-42.","journal-title":"Bulletin of the Johns Hospital"},{"key":"ref_2","first-page":"139","article-title":"Fibrinolytic activity in cirrhosis of the liver","volume":"117","author":"Purcell, G.; Phillips, L.L.","year":"1963","unstructured":"Purcell G, Phillips LL. Fibrinolytic activity in cirrhosis of the liver. Surg Gynecol Obstet 1963;117:139-44.","journal-title":"Surg Gynecol Obstet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI104953","article-title":"Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: its cure and consequences","volume":"43","year":"1964","unstructured":"Fletcher AP, Biederman 0, Moore D, Alkjaersig N, Sherry S. Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: its cure and consequences. J Clin Invest 1964;43:681-95.","journal-title":"J Clin Invest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jcp.24.9.822","article-title":"The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases","volume":"24","author":"Ogston, D.; Bennett, B.; Ogston, C.M.","year":"1971","unstructured":"Ogston D, Bennett B, Ogston CM. The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. Jf Clin Pathol 1971;24:822-6.","journal-title":"Jf Clin Pathol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0002-9343(82)90175-9","article-title":"Reduced histidine rich glycoprotein levels in plasma of patients with advanced liver cirrhosis","volume":"73","author":"Saito, H.","year":"1982","unstructured":"Saito H. Reduced histidine rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Am J Med 1982;73: 179-82.","journal-title":"Am J Med"},{"key":"ref_6","first-page":"671","article-title":"a2-Antiplasmin and its deficiency states","volume":"112","author":"Saito, H.","year":"1988","unstructured":"Saito H. a2-Antiplasmin and its deficiency states. J Lab Clin Med 1988;112:671-8.","journal-title":"J Lab Clin Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood.V69.5.1315.1315","article-title":"The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor","volume":"69","author":"Hersch, S.L.; Kunelis, T.; Frances, R.B.","year":"1987","unstructured":"Hersch SL, Kunelis T, Frances RB. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor. Blood 1987;69: 1315-9.","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/00365528809093922","article-title":"Protease inhibitors in liver disease","volume":"23","author":"Sinclair, T.S.; Booth, N.A.; Penman, S.M.; Brunt, P.W.; Mowat, N.A.G.; Bennett, B.","year":"1988","unstructured":"Sinclair TS, Booth NA, Penman SM, Brunt PW, Mowat NAG, Bennett B. Protease inhibitors in liver disease. ScandJ Gastroenterol 1988;23:620-4.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jcp.37.7.772","article-title":"Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator","volume":"37","author":"Booth, N.A.; Anderson, J.A.; Bennett, B.","year":"1984","unstructured":"Booth NA, Anderson JA, Bennett B. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. J Clin Pathol 1984;37:772-7.","journal-title":"J Clin Pathol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1646877","article-title":"Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis","volume":"62","author":"Tran-Thang, C.; Fasel-Felley, J.; Pralong, G.; Hofsetter, JR, Bachmann; F, Kruithof; E.K.O.","year":"1989","unstructured":"Tran-Thang C, Fasel-Felley J, Pralong G, Hofsetter JR, Bachmann F, Kruithof EKO. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemostas 1989;62:651-3.","journal-title":"Thromb Haemostas"},{"key":"ref_11","first-page":"251","article-title":"Antifibrinolytic activity in primary carcinoma of the liver","volume":"18","author":"Kwaan, H.C.; Lo, R.; McFadzean, A.J.S.","year":"1959","unstructured":"Kwaan HC, Lo R, McFadzean AJS. Antifibrinolytic activity in primary carcinoma of the liver. Clin Sci 1959;18: 251-61.","journal-title":"Clin Sci"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.1988.tb02490.x","article-title":"Plasminogen activator inhibitor (PAI-1) in plasma and platelets","volume":"70","author":"Booth, N.A.; Simpson, A.J.; Croll, A.; Bennett, B.; MacGregor, I.R.","year":"1988","unstructured":"Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. BrJ Haematol 1988;70:327-33.","journal-title":"BrJ Haematol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0268-9499(87)90044-0","article-title":"A monoclonal antibody enzyme-linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator","volume":"1","author":"MacGregor, I.R.; MacDonald, S.; Dawes, J.; Micklem, L.R.; James, K.","year":"1987","unstructured":"MacGregor IR, MacDonald S, Dawes J, Micklem LR, James K. A monoclonal antibody enzyme-linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis 1987;1:247-52.","journal-title":"Fibrinolysis"},{"key":"ref_14","first-page":"2","article-title":"The activity of plasminogen activator inhibitor-l (PAI-1) of human platelet","volume":"4","author":"Booth, N.A.; Croll, A.; Bennett, B.","year":"1990","unstructured":"Booth NA, Croll A, Bennett B. The activity of plasminogen activator inhibitor-l (PAI-1) of human platelet. Fibrinolysis 1990;4(suppl 2):138-40.","journal-title":"Fibrinolysis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1471-0528.1993.tb12982.x","article-title":"Plasminogen activator inhibitors (PAI-i and PAI-2) in normal pregnancies, pre-eclampsia and hydatiform mole","volume":"100","author":"Reith, A.R.; Booth, N.A.; Moore, N.R.; Cruickshank, D.J.; Bennett, B.","year":"1993","unstructured":"Reith AR, Booth NA, Moore NR, Cruickshank DJ, Bennett B. Plasminogen activator inhibitors (PAI-i and PAI-2) in normal pregnancies, pre-eclampsia and hydatiform mole. BrJ Obstet Gynaecol 1993;100:370-4.","journal-title":"BrJ Obstet Gynaecol"},{"key":"ref_16","first-page":"1382","article-title":"A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced","volume-title":"fibrinolysis in cirrhosis. Gastroenterology 1991; 101","author":"Leebeek, F.W.G.; Kluft, C.; Knot, E.A.R.; DeMaat, M.P.M.; Wilson, J.H.P.","unstructured":"Leebeek FWG, Kluft C, Knot EAR, DeMaat MPM, Wilson JHP. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Gastroenterology 1991;101: 1382-90."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0049-3848(91)90022-O","article-title":"Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis","volume":"62","author":"Huber, K.; Kirchheimer, J.C.; Korninger, C.; Binder, B.R.","year":"1991","unstructured":"Huber K, Kirchheimer JC, Korninger C, Binder BR. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. Thromb Res 1991;62:491-500.","journal-title":"Thromb Res"},{"key":"ref_18","first-page":"543","article-title":"The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease","volume":"75","author":"Simpson, A.J.; Booth, N.A.; Moore, N.; Bennett, B.","year":"1990","unstructured":"Simpson AJ, Booth NA, Moore N, Bennett B. The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br I Haematol 1990;75:543-8."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0038-1660092","article-title":"Hepatic clearance of tissue-type plasminogen activator in rats","volume":"54","author":"Emeis, J.I.; van den Hoogen, C.M.; Jense, D.E.","year":"1985","unstructured":"Emeis JI, van den Hoogen CM, Jense DE. Hepatic clearance of tissue-type plasminogen activator in rats. Thromb Haemostas 1985;54:661-4.","journal-title":"Thromb Haemostas"},{"key":"ref_20","first-page":"109","article-title":"Clearance of t-PA, PAI-I and t-PA-PAI-1 complex in an isolated perfused rat liver system","volume":"117","author":"Wing, L.R.; Hawksworth, G.M.; Bennett, B.; Booth, N.A.","year":"1991","unstructured":"Wing LR, Hawksworth GM, Bennett B, Booth NA. Clearance of t-PA, PAI-I and t-PA-PAI-1 complex in an isolated perfused rat liver system. J Lab Clin Med 1991;117:109-14.","journal-title":"J Lab Clin Med"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-5793(91)80092-H","article-title":"The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes","volume":"278","author":"Wing, L.R.; Bennett, B.; Booth, N.A.","year":"1991","unstructured":"Wing LR, Bennett B, Booth NA. The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes. FEBS 1991; 278:95-7.","journal-title":"FEBS"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0268-9499(89)90014-3","article-title":"Plasminogen activator inhibitor (PAI-2) in pregnancy plasma and ovarian cysts, studied by zymography after non-denaturing gel electrophoresis","volume":"3","author":"Reith, A.; Bennett, B.; Booth, N.A.","year":"1989","unstructured":"Reith A, Bennett B, Booth NA. Plasminogen activator inhibitor (PAI-2) in pregnancy plasma and ovarian cysts, studied by zymography after non-denaturing gel electrophoresis. Fibrinolysis 1989;3:159-63.","journal-title":"Fibrinolysis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.1989.tb06311.x","article-title":"The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination","volume":"71","author":"Benett, B.; Booth, N.A.; Croll, A.; Dawson, A.A.","year":"1989","unstructured":"Benett B, Booth NA, Croll A, Dawson AA. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. Br J Haematol 1989;71:511-7.","journal-title":"Br J Haematol"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.47.3.214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:10:42Z","timestamp":1765008642000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.47.3.214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1994,3,1]]},"published-print":{"date-parts":[[1994,3]]}},"alternative-id":["10.1136\/jcp.47.3.214"],"URL":"https:\/\/doi.org\/10.1136\/jcp.47.3.214","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}